USA Today - Aug 1, 2005 Pfizer last month said its sales forces were holding back on fully promoting Celebrex again until it knew the warning language the FDA will require on the ...
FOXNews - Aug 2, 2005 The addition of a warning follows an FDA advisery panel recommendation that stronger warnings be added to Celebrex-type medicines, as well as to older, ...
Free with registration - MMR - AccessMyLibrary.com - Aug 22, 2005 ... the use of Pfizer Inc.'s Celebrex to treat symptoms of ankylosing spondylitis, ... The FDA also finalized the label instructions for all approved uses, ...
Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones - Aug 30, 2005 2005 AUG 30 - (NewsRx.com) -- Pfizer, Inc., reported the US Food and Drug Administration (FDA) has approved the company's selective COX-2 inhibitor Celebrex ...
Pay-Per-View - Datamonitor News and Comment - Factiva, from Dow Jones - Aug 2, 2005 The FDA has approved Pfizer's Celebrex for the treatment of ankylosing spondylitis, a form of arthritis that affects the spine. ...
Free with registration - Skin & Allergy News - AccessMyLibrary.com - Oct 1, 2005 The new warning, a result of an FDA advisory committee's recommendations in February, says that celecoxib (Celebrex) may increase the risk of "thrombotic ...
$4.95 - Pharma Marketletter - ECNext - Aug 8, 2005 "We have worked closely with the FDA to ensure that Celebrex' label ... For the management of the signs and symptoms of ankylosing spondylitis, ...
ABC Regional Online - ABC Regional Online - Feb 8, 2005 "The fact that the FDA gave us a new indication shows they are confident in the safety of Celebrex," Pfizer spokeswoman Mariann Caprino said. ...
Pay-Per-View - Washington Drug Letter - Factiva, from Dow Jones - Aug 8, 2005 The FDA has approved a new black-box warning for Pfizer's arthritis pain drug Celebrex that highlights the increased risk of cardiovascular (CV) events ...
newswise.com - Aug 26, 2005 Many physicians have already been using Celebrex 'off label' for select ankylosing spondylitis patients. The FDA labeling enables doctors to more easily ...
